Lineage Cell Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LCTX and other ETFs, options, and stocks.

About LCTX

Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery.

CEO

Brian M. Culley

CEOBrian M. Culley

Employees

Employees75

Headquarters

Carlsbad, California

HeadquartersCarlsbad, California

Founded

1990

Founded1990

Employees

Employees75

LCTX Key Statistics

Market cap

214.93M

Market cap214.93M

Price-Earnings ratio

-9.22

Price-Earnings ratio-9.22

Dividend yield

—

Dividend yield—

Average volume

999.76K

Average volume999.76K

High today

$1.26

High today$1.26

Low today

$1.12

Low today$1.12

Open price

$1.20

Open price$1.20

Volume

1.10M

Volume1.10M

52 Week high

$1.61

52 Week high$1.61

52 Week low

$0.8414

52 Week low$0.8414

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell